FDA Inspection 1228827 — Novartis D.O.O.
The FDA completed an inspection of Novartis D.O.O. on Sep 21, 2022 in Menges. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 21, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Menges (Slovenia)
Additional details
Mutual Recognition Agreement (MRA)